Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TGFBR2 anticorps (AA 241-330)

TGFBR2 Reactivité: Humain, Souris, Rat, Lapin, Boeuf (Vache) WB, ELISA, IHC (p), IF (cc), IF (p), FACS, IHC (fro) Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN725225
  • Antigène Voir toutes TGFBR2 Anticorps
    TGFBR2 (Transforming Growth Factor, beta Receptor II (70/80kDa) (TGFBR2))
    Épitope
    • 29
    • 15
    • 15
    • 14
    • 11
    • 11
    • 8
    • 7
    • 7
    • 7
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 241-330
    Reactivité
    • 112
    • 94
    • 52
    • 21
    • 19
    • 7
    • 4
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain, Souris, Rat, Lapin, Boeuf (Vache)
    Hôte
    • 131
    • 7
    • 5
    • 5
    • 2
    Lapin
    Clonalité
    • 143
    • 6
    • 1
    Polyclonal
    Conjugué
    • 60
    • 12
    • 9
    • 9
    • 7
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 1
    Cet anticorp TGFBR2 est non-conjugé
    Application
    • 106
    • 56
    • 38
    • 38
    • 35
    • 20
    • 19
    • 18
    • 10
    • 9
    • 4
    • 2
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Flow Cytometry (FACS), Immunohistochemistry (Frozen Sections) (IHC (fro))
     Réactivité croisée
    Boeuf (Vache), Humain, Souris, Lapin, Rat
    Homologie
    Sheep,Pig,Horse,Chicken
    Purification
    Purified by Protein A.
    Immunogène
    KLH conjugated synthetic peptide derived from human TGF beta R2
    Isotype
    IgG
    Top Product
    Discover our top product TGFBR2 Anticorps primaire
  • Indications d'application
    WB 1:300-5000
    ELISA 1:500-1000
    FCM 1:20-100
    IHC-P 1:200-400
    IHC-F 1:100-500
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 μg/μL
    Buffer
    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
    Date de péremption
    12 months
  • Friedrichs, Fink, Mauch, Kindler, Hartmann, Schüle, Buettner, Friedrichs: "TGF-?1-dependent induction and nuclear translocation of FHL2 promotes keratin expression in pilomatricoma." dans: Virchows Archiv : an international journal of pathology, Vol. 466, Issue 2, pp. 199-208, (2015) (PubMed).

    Hirayama, Koyama, Sawai, Fujii, Naito, Fukuda, Kageyama: "Localization of TGF-? and TGF-? receptor in bovine term placentome and expression differences between spontaneous and induced parturition." dans: Placenta, Vol. 36, Issue 11, pp. 1239-45, (2015) (PubMed).

    Abdelmagid, Belcher, Moussa, Lababidi, Sondag, Novak, Sanyurah, Frara, Razmpour, Del Carpio-Cano, Safadi: "Mutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro." dans: The American journal of pathology, Vol. 184, Issue 3, pp. 697-713, (2014) (PubMed).

    Li, Li, Pan, Jin: "TNF-α enhances the effect of TGF-β on Gli2 expression in the KG-1 leukemic cell line." dans: Experimental and therapeutic medicine, Vol. 8, Issue 2, pp. 676-680, (2014) (PubMed).

  • Antigène
    TGFBR2 (Transforming Growth Factor, beta Receptor II (70/80kDa) (TGFBR2))
    Autre désignation
    TGF beta Receptor 2 (TGFBR2 Produits)
    Sujet

    Synonyms: AAT3, FAA3, LDS2, MFS2, RIIC, LDS1B, LDS2B, TAAD2, TGFR-2, TGFbeta-RII, TGF-beta receptor type-2, TGF-beta type II receptor, Transforming growth factor-beta receptor type II, TGF-beta receptor type II, TbetaR-II, TGFBR2

    Background: Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 Molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFRB1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways.

    ID gène
    7048
    UniProt
    P37173
Vous êtes ici:
Support technique